Our Expertise

CoDx supports biotechnology and medical diagnostics stakeholders in their strategic, scientific, and partnership challenges. We work at different development stages, from proof of concept to post-R&D valorization and transfer to production.

Our service offering is built around 4 key competencies:

Strategic & business consulting

We provide tailored support to healthcare project leaders in structuring their business model, defining a clear roadmap, establishing functional specifications including marketing and client requirements, and preparing strategic documents for investors or institutional partners.

Pitch deck & fundraising

Strategic roadmap

Business plan and P&L preparation

Marketing positioning analysis

Diagnostics & biomarkers

CoDx has extensive expertise in biomarker development, proof-of-concept (PoC) studies, and analytical validation within personalised medicine projects (including companion diagnostics) and more broadly across the medical diagnostics field.

Biomarker development support

Analytical verification

Clinical validation studies (biomarkers)

Personalised medicine and companion diagnostics

Regulatory compliance

Partnerships & ecosystem

We help the integration of client's projects into a coherent ecosystem by leveraging our networks of experts, institutions, KOLs and investors. Our goal: strengthening the legitimacy, reach and sustainability of the initiatives we support for optimal client's satisfaction.

Integration into healthcare networks and Targeted networking

Institutional visibility

Support for grant applications, particularly European Commission programmes (HE, IHI, EIC, etc.)

Access to KOLs and experts (including IVD and MDR regulations)

Licensing & technology transfer

We support project leaders in maximising the value of their innovations through licensing agreements, technology transfers and strategic partnerships between laboratories, universities and industry players.

Licensing-in and -out support

R&D results valorisation

Agreement structuring

Academia-industry bridging

Intellectual property advising

What our clients and partners say?

"I had the pleasure of working with Catherine for 3 years. She is one of the most brilliant people I have ever met: exceptional scientific rigour, an outstanding ability to build connections, a sharp eye for detail and true professional integrity. Working with Catherine is the guarantee of an efficient, smooth, human and inspiring collaboration. You only want one thing afterwards: to work with her again."
Pierre Vidal
CEA — Développement de Partenariats Industriels
"I have always valued our exchanges: Catherine is attentive, professional and open to discussion. Whether at Bio-Rad or later at Singulex, she has always demonstrated a great openness, a willingness to co-build and a rare ability to understand business challenges. Working with her means learning, finding inspiration, and moving ideas forward."
David Hagebush
Director of Clinical Marketing and Business Development – NOVODIAX, INC.
"Dr. Catherine Larue is an excellent mentor. We collaborated for two years on the development of novel cardiac marker immunoassays. Catherine is a thoughtful leader, who listens attentively, provides helpful feedback and encouragement, and never discounts a colleague's point of view. I learned so much from Dr. Larue while working with her."
Todd Pederson
Collaborator
"I had the opportunity to work with Catherine for over 10 years in a medical diagnostics company. Her dynamism and expertise in the field of diagnostics are undeniable. I can say that she has been my mentor in this field, always demonstrating the utmost professionalism. This is evidenced by her international career in medical diagnostics and companion diagnostics. Her creativity and vision in this field are a guarantee of quality in this rapidly changing industry. The creation of CoDx International is essential in this competitive and forward-looking field. All the best to you Catherine!"
Jeannette FAREH
LNE/GMED — Examinateur de produits - Clinicien Interne
"It has been a great pleasure working with Catherine when she had joined the supervisory board of and I had joined NASDAQ-listed Quotient ltd, now AliveDx, as CTO and global head of R&D. Her industry and key opinion leader network, her vast and international leadership experience, her scientific and product development depth have been of high value to the company, the R&D teams in Switzerland and Scotland and me and will be to any diagnostic or life science business. While a board – executive management relationship isn’t always a most simple one to navigate, her openness, curiosity, collegial style, eagerness to support and advise to solve highly complex problems were greatly appreciated."
Michael Hausma
AliveDx — Chief Technology Officer & Global Head of R&D